Jasper Therapeutics, Inc.
JSPR • NASDAQ
Jasper Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jeetinder Singh Mahal, with a market cap of $29.4M.
CEOJeetinder Singh Mahal
Next Earnings
Upcoming earnings announcement for Jasper Therapeutics, Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.51
Earnings History
Past 12 earnings reports for Jasper Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Q4 2025 | -$0.32Est: -$0.81 | +60.5% | - | — |  10-K |
| Nov 10, 2025 | Q3 2025 | -$1.13Est: -$1.18 | +4.2% | - | — | 10-Q |
| Aug 13, 2025 | Q2 2025 | -$1.74Est: -$1.28 | -35.9% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$1.41Est: -$1.48 | +4.7% | - | — | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$1.62Est: -$1.26 | -28.6% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$1.24Est: -$1.07 | -15.9% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.97Est: -$1.09 | +11.0% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$1.03Est: -$1.23 | +16.3% | - | — | 10-Q |
| Mar 4, 2024 | Q4 2023 | -$1.50Est: -$1.61 | +6.8% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$1.60Est: -$1.50 | -6.7% | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$1.50Est: -$1.50 | 0.0% | - | — | 10-Q |
| May 12, 2023 | Q1 2023 | -$1.60Est: -$4.20 | +61.9% | - | — | — |